Vimian Group AB Stock price

Equities

VIMIAN

SE0015961982

Pharmaceuticals

Market Closed - Nasdaq Stockholm 11:29:35 2024-02-28 am EST 5-day change 1st Jan Change
29.74 SEK -1.39% Intraday chart for Vimian Group AB +2.55% +0.47%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site

Financials

Sales 2023 332M 360M 3.72B Sales 2024 * 372M 403M 4.16B Capitalization 1.21B 1.31B 13.59B
Net income 2023 9M 9.75M 101M Net income 2024 * 41M 44.43M 459M EV / Sales 2023 3.66 x
Net Debt 2023 * 244M 265M 2.73B Net Debt 2024 * 276M 299M 3.09B EV / Sales 2024 * 4.01 x
P/E ratio 2023
133 x
P/E ratio 2024 *
32 x
Employees 1,000
Yield 2023 *
-
Yield 2024 *
-
Free-Float 31.85%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.39%
1 week+2.55%
Current month+4.13%
1 month+4.35%
3 months+18.11%
6 months+4.57%
Current year+0.47%
More quotes
1 week
27.62
Extreme 27.62
30.62
1 month
27.34
Extreme 27.34
31.50
Current year
25.14
Extreme 25.14
31.50
1 year
20.08
Extreme 20.08
37.96
3 years
20.08
Extreme 20.08
123.40
5 years
20.08
Extreme 20.08
123.40
10 years
20.08
Extreme 20.08
123.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 Dec. 31
Director of Finance/CFO 45 21-12-31
Investor Relations Contact 43 21-08-31
Members of the board TitleAgeSince
Director/Board Member 65 20-12-31
Director/Board Member 57 21-12-31
Director/Board Member 54 22-12-31
More insiders
Date Price Change Volume
24-02-28 29.74 -1.39% 385,999
24-02-27 30.16 +3.64% 710,354
24-02-26 29.1 +0.97% 629,395
24-02-23 28.82 +2.13% 384,662
24-02-22 28.22 +1.15% 155,928

Delayed Quote Nasdaq Stockholm, February 28, 2024 at 11:29 am EST

More quotes
Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
2.654 EUR
Average target price
3.48 EUR
Spread / Average Target
+31.12%
Consensus
  1. Stock
  2. Equities
  3. Stock Vimian Group AB - Nasdaq Stockholm
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW